Home » MEDREG

Tag: MEDREG

Post
Foghorn Therapeutics pauses enrollment in cancer drug study

Foghorn Therapeutics pauses enrollment in cancer drug study

April 24 (Reuters) – Drug developer Foghorn Therapeutics Inc (FHTX.O) said on Monday it has paused enrollment in an early-stage study of the company’s experimental drug for a rare form of cancer due to safety concerns. The company said the U.S. Food and Drug Administration has also placed the study on partial hold in the...